(redirected from Invasive Fungal Infection)
IFIIrish Film Institute (est. 1943)
IFIInternational Financial Institutions (IMF, World Bank, etc.)
IFIInnovation First, Inc. (combat robotic equipment manufacturer)
IFIIslamic Foundation of Ireland
IFIInstitutt For Informatikk (Department of Informatics, University of Oslo)
IFIInstrumentation Facility Interface
IFIIndustrial Fasteners Institute (trade association)
IFIInstituciones Financieras Internacionales (Spanish: International Financial Institutions)
IFIInternational Fabricare Institute
IFIInnerChange Freedom Initiative
IFIIglesia Filipina Independiente (Independent Philippine Church)
IFIInvasive Fungal Infection
IFIInternational Food Ingredients (publication)
IFIInstitut de la Francophonie pour l'Informatique (Hanoi, Vietnam)
IFIIndiana Family Institute (Indianapolis, IN)
IFIIntensive Family Intervention (behavioral health)
IFIInternational Finance Institute
IFIInternational Fixed Income
IFIIstituti Finanziari Internazionali (Italian: International Financial Institutions)
IFIInternational Federation of Interior Designers
IFIInternational Flood Initiative
IFIInstitut de Formation International (French: International Training Institute)
IFIIngeniero Fisico Industrial (Mexico)
IFIIn-Flight Insertion
IFIInspection Follow-Up Item
IFIIntegrated Facilities and Infrastructure
IFIIssued for Information
IFIInternet Finance International
References in periodicals archive ?
Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-beta-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.
Measuring the serum or plasma BDG levels has a high level of accuracy in the discrimination of patients with and without invasive fungal infections, mainly invasive fungal infections due to Candida or Aspergiilus.
Post ASCT, invasive fungal infection [IFI] usually occurs in pre-engraftment period however can happen after count recovery as well.
The current increment of invasive fungal infections and the availability of new broad-spectrum antifungal agents has increased the use of these agents by non-expert practitioners, without an impact on mortality.
Patients with invasive fungal infection had a higher incidence of intraperitoneal leak documented during surgery compared to patients with nonfungal infections (90% versus 69%, p value 0.01) (Table 2).
IFI was diagnosed when at least one of the following three conditions were presented: 1) positive culture from normally sterile sites (e.g., blood or cerebrospinal fluid specimens) or deep tissue specimens, and/or the presence of budding yeast, hyphae, or pseudo-hyphae; 2) histopathological examination of samples collected by needle aspiration or from a biopsy specimen showing hyphae or yeast with evidence of associated tissue damage (i.e., either microscopically or unequivocally demonstrated by imaging analysis); 3) fungal colonization that was not classified as an invasive fungal infection unless this was supported by the same positive culture outcome from two independent occasions, or from clinical and/or radiological evidence and/ or in response to anti-fungal agents (14).
The demographic data, treatment risk groups, treatment features, presence of relapse, frequency of febrile neutropenia, causative microorganisms of febrile neutropenia attacks, invasive fungal infections, culture results and disease prognosis were evaluated retrospectively from patients' files.
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
During the weekly Thursday Theater Combat Casualty Care conference, colleagues at Walter Reed National Military Medical Center reported on casualties with progressively invasive fungal infections. This feedback to theater prompted a series of teleconferences moderated by the Joint Theater Trauma System Director.
The risk of development of an invasive fungal infection (IFI) is 15-25% in high-risk patient groups, particularly those with a long history of neutropenia, organ damage, and prior fungal infection or colonization in hematological cancer or transplant cases [1].
Full browser ?